Brigham and Women's Hospital
Chestnut Hill, Massachusetts, 02467, United States
NCT Number: NCT01502644
Opioids are frequently prescribed for chronic low back pain (CLBP). Psychiatric illness, such as high levels of depression and anxiety symptoms, is a common co-occurrence in chronic pain patients (and is termed comorbid negative affect [NA]). The purpose of the study is to determine whether CLBP patients with either a high vs. a low or moderate degree of NA have different pain relief responses to oral opioids.
Looking for future studies?
Notify Me21 year–75 year
All sexes
Interventional
Phase 4
Chestnut Hill, Massachusetts, 02467, United States
The level of high, moderate or low NA was determined based on the participant's score on the Hospital Anxiety and Depression Scale (HADS). The HADS is a self-reported questionnaire that has 14 questions related to 2 domains: Anxiety subscale (7 questions) and Depression subscale (7 questions). Each item on the questionnaire is scored from 0 (least amount of anxiety/depression) to 3 (greatest amount of anxiety/depression), with total score between 0 and 21 for either anxiety or depression. Participants were assigned to high, moderate or low NA groups using the following HADS score criteria:
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Daily dosage up to 120 mg
Daily dosage up to 90 mg immediate release or 180 mg extended release
Other names: Morphine sulfate (MS) Contin, Morphine sulfate instant release (MSIR), Morphine sulfate extended release (MSER)
Placebo-matching oxycodone, placebo-matching morphine
Time frame: Baseline and Week 20
Participants rated their average lower back pain over the past 24 hours using an 11-point scale (0=no pain to 10=worst possible pain) and recorded it in an electronic diary. The percent change in pain score from baseline is calculated using weekly averages for up to 20 weeks. Linear mixed modeling (LMM) analysis was used to allow for inclusion in the analysis of the majority of participants with any missing data. For the LMM model, group, group × week, average baseline pain, and opioid use at baseline (yes/no) were entered as fixed effects using an autoregressive covariance structure. Participant, intercept, and week were entered as random effects, using a compound symmetry covariance structure. A positive change from baseline indicates an improvement.
Brigham and Women's Hospital
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT02697435
Anxiety, Anxiety Disorders
Pittsburgh, Pennsylvania, United States
View Trial DetailsNCT04747314
Anxiety Disorders, Back Pain
Chestnut Hill, Massachusetts, United States
View Trial DetailsNCT06419439
Back Pain, Behavior
Ann Arbor, Michigan, United States
View Trial DetailsNCT04849429
Bone Diseases, Chronic Low Back Pain
Rudrapur, Uttarakhand, India
View Trial Details